Log in to save to my catalogue

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e769071990584a6aa031c02542686ae3

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

About this item

Full title

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-03, Vol.13 (1), p.1700-1700, Article 1700

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Anti-PD-1/PD-L1 immunotherapy has achieved impressive therapeutic outcomes in patients with multiple cancer types. However, the underlined molecular mechanism(s) for moderate response rate (15–25%) or resistance to PD-1/PD-L1 blockade remains not completely understood. Here, we report that inhibiting the deubiquitinase, USP8, significantly enhances...

Alternative Titles

Full title

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e769071990584a6aa031c02542686ae3

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e769071990584a6aa031c02542686ae3

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-29401-6

How to access this item